Company profile
life sciences, agriculture, consumer health · Leverkusen, Germany · bayer.com
Bayer is a global life sciences company with three main businesses, Pharmaceuticals, Crop Science, Consumer Health. Its current direction emphasizes innovation-led growth, operational simplification, heavy use of data and AI across research, development, manufacturing, internal work processes.
The company says it creates value through innovative products, new process and business models, strategic partnerships.
Annual report states that activities focus on innovative products and that partnerships are integral to the innovation strategy.
Crop Science remains a major strategic focus with a multi-year framework and regenerative agriculture emphasis.
The annual report says Crop Science is pursuing a five-year framework and a strategic plan for sales growth, margin improvement, pipeline strengthening, regenerative agriculture.
Pharmaceuticals is being supported by continued pipeline expansion and commercial launches.
The chairman letter highlights launch execution, pipeline rebuilding, approvals for key assets, while results show pharma sales growth and continued R&D investment.
Management is pushing new operating models and productivity measures across functions.
The annual report and compensation section describe dynamic operating models, resource allocation changes, process simplification, including the start of Workday implementation.
Bayer shows a cloud forward, data intensive technology posture, with AI, software engineering, enterprise process modernization treated as core capabilities.
Public disclosures point to cloud based innovation platforms, stronger data governance, enterprise workflow modernization.
This is a neutral public preview. Sign in to generate your own personalized brief, with stakeholder angles, talk tracks and where your solution fits, tailored to how you sell.
Generate a full briefYour first brief is free, no card required.
Evidence confidence 89/100. Generated 2026-07-03 from public sources.